Clinical Development

Balancing the clinical scales

Outsourcing-Pharma focus on: cutting the cost of clinical trials

Balancing the clinical scales

By Kirsty Barnes

As pharma companies flock towards Eastern Europe and India in a bid
to cut direct clinical trial costs, does outsourcing actually
translate into real world cost-savings?

Use 'The Net' to catch your fish

Outsourcing-Pharma Focus: Cutting the cost of clinical trials

Use 'The Net' to catch your fish

By Kirsty Barnes

Patient recruitment consumes more time than any other clinical
trial activity, costing the industry millions of dollars. However,
recruiting patients on the Internet can slash recruitment times and
bring drugs to market faster.

PRA moves profits forward

PRA moves profits forward

By Kirsty Barnes

Despite a dip in revenue, PRA International saw its profit grow 53
per cent in the fourth quarter of 2005 to reach $7.5m (€6.3m) on
the back of improved margins. The global clinical research
organization (CRO) also saw a similar growth...

Perceptive is just that

Perceptive is just that

By staff reporter

Perceptive Informatics, a subsidiary of Parexel, has released the
latest version of its web interface for data capture, patient
randomisation and the management of study drug inventory for
clinical trials.

Q3 revenues dip for Pharsight

Q3 revenues dip for Pharsight

By Kirsty Barnes

Pharsight, a provider of software and strategic services for
clinical drug development, has seen its revenues dip for the second
quarter in a row due to lower-than-expected business from a top
client in its strategic consulting services...

Phase IIIB-IV research booming

Outsourcing-Pharma: Focus on Phase IIIB-IV research

Phase IIIB-IV research booming

By Kirsty Barnes

Phase IIIB-IV clinical research in the US is now booming, growing
20 per cent annually, compared with only 7 per cent for Phase
II-III research, driven by a surge in public drug safety concerns
and increased drug market competitiveness.

Covance ends 2005 on the upswing

Covance ends 2005 on the upswing

By Kirsty Barnes

Covance closed 2005 on a high after net revenues climbed 16.9 per
cent from 2004 to reach $1.19 bn (€1 bn). The current trend towards
outsourcing R&D, coupled with increased productivity and repeat
business has fuelled the company's...

Follow us

Products

View more

Webinars